Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa

This publication has 24 references indexed in Scilit:

• Mucosal vaccination with a recombinant OprF-I vaccine ofPseudomonas aeruginosain healthy volunteers: comparison of a systemic vs. a mucosal booster schedule
  FEMS Immunology & Medical Microbiology, 2003
• Protection against FatalPseudomonas aeruginosaPneumonia in Mice after Nasal Immunization with a Live, AttenuatedaroADeletion Mutant
  Infection and Immunity, 2003
• Early infection and progression of cystic fibrosis lung disease
  Pediatric Pulmonology, 2002
• Protection of Mice against Brucellosis by Intranasal Immunization withBrucella melitensisLipopolysaccharide as a Noncovalent Complex withNeisseria meningitidisGroup B Outer Membrane Protein
  Infection and Immunity, 2002
• Lung Infections Associated with Cystic Fibrosis
  Clinical Microbiology Reviews, 2002
• Intranasal Immunization with Pneumococcal Conjugate Vaccines with LT-K63, a Nontoxic Mutant of Heat-Labile Enterotoxin, as Adjuvant Rapidly Induces Protective Immunity against Lethal Pneumococcal Infections in Neonatal Mice
  Infection and Immunity, 2002
• Systemic and Mucosal Immune Responses in Mice after Mucosal Immunization with Group B Streptococcus Type III Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccine
  Infection and Immunity, 2000
• Nasal Immunization InducesHaemophilus influenzae–specific Th1 and Th2 Responses with Mucosal IgA and Systemic IgG Antibodies for Protective Immunity
  The Journal of Infectious Diseases, 1999
• Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
  The Journal of Pediatrics, 1995
• Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa
  The Journal of Infectious Diseases, 1994